Panacea Life Sciences Holdings, Inc. Assets, Fair Value Disclosure
Panacea Life Sciences Holdings, Inc. (PLSH) had Assets, Fair Value Disclosure of $9.50 thousand as of 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2024-05-06
- 2024-03-31: Assets, Fair Value Disclosure $9.50K.
- 2023-12-31: Assets, Fair Value Disclosure $14.93K.
- 2023-09-30: Assets, Fair Value Disclosure $78.42K.
- 2023-06-30: Assets, Fair Value Disclosure $460.39K.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2024-03-31 | $9.50K 10-Q · filed 2024-05-06 |
| 2023-12-31 | $14.93K 10-Q · filed 2024-05-06 |
| 2023-09-30 | $78.42K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $460.39K 10-Q · filed 2023-08-15 |
| 2023-03-31 | $925.11K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.11M 10-K · filed 2024-04-01 |
| 2022-09-30 | $1.12M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.56M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.85M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $3.79M 10-K · filed 2023-03-30 |
| 2021-09-30 | $3.63M 10-Q/A · filed 2021-12-20 |
| 2021-06-30 | $6.01M 10-Q/A · filed 2021-12-20 |
| 2020-12-31 | $2.85M 10-K · filed 2022-03-31 |